Targeting dementias through cancer kinases inhibition

Area of Science:

• Neuroscience
• Oncology
• Biochemistry

Background:

• Alzheimer's disease (AD) and other neurodegenerative dementias involve complex cellular dysfunctions, including neurotransmitter imbalance, neuroinflammation, and cell cycle abnormalities.
• Current therapeutic strategies for AD have largely failed, necessitating a re-evaluation of research approaches and the exploration of novel molecular targets.

Purpose of the Study:

• To investigate the potential of targeting the kinome, specifically cancer kinases, as a therapeutic strategy for neurodegeneration in Alzheimer's disease.
• To identify intracellular pathways at the intersection of cell metabolism, duplication, and neurodegeneration that can be targeted for therapeutic intervention.

Main Methods:

• Review of existing literature on Alzheimer's disease, neurodegeneration, cancer biology, and kinase signaling pathways.
• Analysis of the relationship between cancer-related kinases and cellular processes implicated in neurodegenerative diseases.

Main Results:

• The kinome, representing the intracellular signaling machinery, is implicated in various defects observed in AD, including signaling imbalance and aberrant cell cycles.
• A strong correlation exists between cancer and AD, suggesting that cancer kinases, which regulate cell metabolism and duplication, are promising targets for neurodegenerative diseases.

Conclusions:

• Targeting intracellular pathways involving cancer kinases offers a promising strategy to inhibit neurodegeneration by intervening in cell metabolism and duplication processes.
• Repurposing knowledge from cancer research, particularly regarding kinase inhibitors, could lead to novel therapeutic avenues for Alzheimer's disease and related dementias.